Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics
SAGE Price/Volume Stats
| Current price | $6.85 | 52-week high | $13.47 |
| Prev. close | $6.78 | 52-week low | $4.62 |
| Day low | $6.61 | Volume | 772,600 |
| Day high | $6.90 | Avg. volume | 1,490,351 |
| 50-day MA | $7.10 | Dividend yield | N/A |
| 200-day MA | $6.93 | Market Cap | 428.95M |
SAGE Stock Price Chart Interactive Chart >
Sage Therapeutics, Inc. (SAGE) Company Bio
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders. The company was founded in 2010 and is based in Cambridge, Massachusetts.
SAGE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SAGE Price Returns
| 1-mo | 2.09% |
| 3-mo | -8.67% |
| 6-mo | 23.20% |
| 1-year | -35.26% |
| 3-year | -81.75% |
| 5-year | -81.95% |
| YTD | 26.15% |
| 2024 | -74.94% |
| 2023 | -43.18% |
| 2022 | -10.34% |
| 2021 | -50.83% |
| 2020 | 19.84% |